| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10520629 | Transfusion Clinique et Biologique | 2005 | 6 Pages |
Abstract
Conclusion. - New therapies, molecules coming from the research, recombinant proteins or coming from the plasma fractionation will certainly modify the indications of the fresh plasma frozen in the coming years. The supervision of our practices remains essential.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
C. Boulat, B. Clero,